A Pill or Injection for Clearing Atopic Skin? Real World Insights with Dr.Ashley O'Toole

30/08/2021 37 min Temporada 1 Episodio 2
A Pill or Injection for Clearing Atopic Skin? Real World Insights with Dr.Ashley O'Toole

Listen "A Pill or Injection for Clearing Atopic Skin? Real World Insights with Dr.Ashley O'Toole"

Episode Synopsis

Episode Learning Objectives · Explore  assessment strategies  based on  disease activity  to guide treatment decisions for moderate to severe atopic dermatitis· Apply current evidence as well as shared decision-making to  individualize therapy decisions for patients with moderate to severe atopic dermatitis; specifically real world experience around dupilumab (DUPIXENT) and a recent publication exploring  upadacitinib (RINVOQ), an experimental indication for AD vs dupilumab· Implement strategies to improve interprofessional care coordination between primary care providers and specialty care providers and address the unmet needs of patientsABOUT DR.ASHLEY O'TOOLE, MHSc, MD, FRCPC:Dr. O’Toole is a dermatologist with the SKiN Centre for Dermatology in Peterborough, Ontario where she also serves as a sub-investigator for multiple clinical trials. She is an adjunctive professor at Queens University and involved in teaching medical students and residents and holds medical privileges at the Peterborough Regional Health Centre. After receiving a Master’s of Health Science in Health and Behavioural Communication at Ryerson University in Toronto, Ontario, Dr. O’Toole received her medical degree from McMaster University in Hamilton, Ontario, and completed her residency in dermatology at the University of Ottawa in Ottawa, Ontario. Dr. O’Toole is the author or co-author of over 20 peer-reviewed publications and has been involved ias a sub-investigator for over 40 clinical trials on atopic dermatitis, psoriasis, alopecia, acne and vitiligo. Disclaimer: This is an educational podcast only and does not replace professional medical advice. Please consult your healthcare provider for any health issues. Discussed:HEADS UP Trial: https://jamanetwork.com/journals/jamadermatology/fullarticle/2782803Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis: https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.15053  Supported by IMEs from  Janssen and Lilly www.skinandjoints.ca
📻www.skinandjoints.ca✉️[email protected] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More episodes of the podcast Skin and Joints Podcast